Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia

被引:73
作者
Na, Kyeong-Sae [1 ]
Kim, Yong-Ku [1 ,2 ]
机构
[1] Korea Univ, Dept Psychiat, Seoul 136701, South Korea
[2] Korea Univ, Div Brian Korea 21 Biomed Sci, Seoul 136701, South Korea
关键词
antipsychotics; cytokines; interleukins; interferons; psychoimmunology; schizophrenia;
D O I
10.1159/000111535
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A growing body of evidence suggests that changes in the serum levels and cellular production of various cytokines are associated with the immunological abnormalities of schizophrenia. Several studies have examined alterations in T helper type 1 (Th1) and T helper type 2 (Th2) cytokines in schizophrenia. We explored monocytic, Th1 and Th2 cytokines in 43 schizophrenia patients and 50 normal controls. The mitogen-induced production of tumor necrosis factor alpha (TNF- alpha), interleukin 6 (IL-6), IL-4, gamma-interferon (IFN-gamma) and IL-2 was measured with enzyme-linked immunosorbent assays before and after antipsychotic treatment. IL-6 and TNF-alpha production by schizophrenic patients was significantly higher than by normal controls, while IL-2, IL-4 and IFN-gamma production was significantly lower in schizophrenic patients. After 6 weeks of antipsychotic treatment, IL-6 and TNF-alpha production was significantly decreased, while IL-4, IFN-gamma and IL-2 productions were not significantly changed. Our results suggest that increased monocytic cytokines and decreased Th1 and Th2 cytokines may be associated with the immuno-pathogenesis of acute psychotic schizophrenia, and that antipsychotics may play an important role in immune response by decreasing elevated monocytic cytokines. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 75 条
[1]  
[Anonymous], 1994, AM PSYCHIATR ASSOC
[2]   Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment [J].
Arolt, V ;
Rothermundt, M ;
Wandinger, KP ;
Kirchner, H .
MOLECULAR PSYCHIATRY, 2000, 5 (02) :150-158
[3]   Serum cytokine concentrations in patients with schizophrenia [J].
Baker, I ;
Masserano, J ;
Wyatt, RJ .
SCHIZOPHRENIA RESEARCH, 1996, 20 (1-2) :199-203
[4]   Blood-brain barrier transport of cytokines: A mechanism for neuropathology [J].
Banks, WA .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (08) :973-984
[5]  
Barak V, 1995, J Basic Clin Physiol Pharmacol, V6, P61
[6]   INTERLEUKIN-6 AND ALPHA-2-MACROGLOBULIN INDICATE AN ACUTE-PHASE STATE IN ALZHEIMERS-DISEASE CORTICES [J].
BAUER, J ;
STRAUSS, S ;
SCHREITERGASSER, U ;
GANTER, U ;
SCHLEGEL, P ;
WITT, I ;
YOLK, B ;
BERGER, M .
FEBS LETTERS, 1991, 285 (01) :111-114
[7]   CYTOKINE PRODUCTION IN DRUG-FREE AND NEUROLEPTIC-TREATED SCHIZOPHRENIC-PATIENTS [J].
BESSLER, H ;
LEVENTAL, Z ;
KARP, L ;
MODAI, I ;
DJALDETTI, M ;
WEIZMAN, A .
BIOLOGICAL PSYCHIATRY, 1995, 38 (05) :297-302
[8]   DISTRIBUTION AND CHARACTERIZATION OF TUMOR NECROSIS FACTOR-ALPHA-LIKE IMMUNOREACTIVITY IN THE MURINE CENTRAL-NERVOUS-SYSTEM [J].
BREDER, CD ;
TSUJIMOTO, M ;
TERANO, Y ;
SCOTT, DW ;
SAPER, CB .
JOURNAL OF COMPARATIVE NEUROLOGY, 1993, 337 (04) :543-567
[9]   Ageing and the neutrophil: no appetite for killing? [J].
Butcher, S ;
Chahel, H ;
Lord, JM .
IMMUNOLOGY, 2000, 100 (04) :411-416
[10]   Cytokine profiles in schizophrenic patients treated with risperidone - A 3-month follow-up study [J].
Cazzullo, CL ;
Sacchetti, E ;
Galluzzo, A ;
Panariello, A ;
Adorni, A ;
Pegoraro, M ;
Bosis, S ;
Colombo, F ;
Trabattoni, D ;
Zagliani, A ;
Clerici, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (01) :33-39